{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:08:20Z","timestamp":1791259700344,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIH\/NINDS","award":["2P01-NS092521"],"award-info":[{"award-number":["2P01-NS092521"]}]},{"name":"NIH\/NINDS","award":["2P01-NS092521"],"award-info":[{"award-number":["2P01-NS092521"]}]},{"name":"National Organization for Rare Diseases","award":["32001"],"award-info":[{"award-number":["32001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"DOI":"10.1186\/s40246-025-00886-8","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T17:26:22Z","timestamp":1765301182000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recurrent somatic copy number alterations in resected cerebral cavernous malformations"],"prefix":"10.1186","volume":"20","author":[{"given":"Andrew K.","family":"Ressler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evon","family":"Debose-Scarlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Fuenzalida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda","family":"Lightle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shantel","family":"Weinsheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie E.","family":"Faughnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edda","family":"Spiekerkoetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Schimmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lawton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issam","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Marchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"886_CR1","first-page":"201","volume":"59","author":"E Trapani","year":"2015","unstructured":"Trapani E, Retta SF. Cerebral cavernous malformation (CCM) disease: from Monogenic forms to genetic susceptibility factors. J Neurosurg Sci. 2015;59:201\u20139.","journal-title":"J Neurosurg Sci"},{"key":"886_CR2","doi-asserted-by":"publisher","unstructured":"Clinical genomic. and Histopathologic diversity in cerebral cavernous malformations | acta neuropathologica communications | full text. https:\/\/actaneurocomms.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s40478-025-01940-1","DOI":"10.1186\/s40478-025-01940-1"},{"key":"886_CR3","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/hmg\/ddn430","volume":"18","author":"AL Akers","year":"2009","unstructured":"Akers AL, Johnson E, Steinberg GK, Zabramski JM, Marchuk DA. Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum Mol Genet. 2009;18:919\u201330.","journal-title":"Hum Mol Genet"},{"key":"886_CR4","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1111\/j.1742-4658.2009.07535.x","volume":"277","author":"F Riant","year":"2010","unstructured":"Riant F, Bergametti F, Ayrignac X, Boulday G, Tournier-Lasserve E. Recent insights into cerebral cavernous malformations: the molecular genetics of CCM. FEBS J. 2010;277:1070\u20135.","journal-title":"FEBS J"},{"key":"886_CR5","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.1093\/brain\/awad104","volume":"146","author":"J Ren","year":"2023","unstructured":"Ren J, et al. Somatic variants of MAP3K3 are sufficient to cause cerebral and spinal cord cavernous malformations. Brain. 2023;146:3634\u201347.","journal-title":"Brain"},{"key":"886_CR6","doi-asserted-by":"crossref","unstructured":"Huo R et al. Simplex cerebral cavernous malformations with MAP3K3 mutation have distinct clinical characteristics. Front Neurol 13, (2022).","DOI":"10.3389\/fneur.2022.946324"},{"key":"886_CR7","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1056\/NEJMoa2100440","volume":"385","author":"M Peyre","year":"2021","unstructured":"Peyre M, et al. Somatic PIK3CA mutations in sporadic cerebral cavernous malformations. N Engl J Med. 2021;385:996\u20131004.","journal-title":"N Engl J Med"},{"key":"886_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41586-021-03562-8","volume":"594","author":"AA Ren","year":"2021","unstructured":"Ren AA, et al. PIK3CA and CCM mutations fuel Cavernomas through a cancer-like mechanism. Nature. 2021;594:271\u20136.","journal-title":"Nature"},{"key":"886_CR9","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s44161-022-00035-7","volume":"1","author":"DA Snellings","year":"2022","unstructured":"Snellings DA, et al. Developmental venous anomalies are a genetic primer for cerebral cavernous malformations. Nat Cardiovasc Res. 2022;1:246\u201352.","journal-title":"Nat Cardiovasc Res"},{"key":"886_CR10","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1038\/s41467-017-02002-4","volume":"8","author":"IM Berenjeno","year":"2017","unstructured":"Berenjeno IM, et al. Oncogenic PIK3CA induces centrosome amplification and tolerance to genome doubling. Nat Commun. 2017;8:1773.","journal-title":"Nat Commun"},{"key":"886_CR11","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/s41586-022-04738-6","volume":"606","author":"CD Steele","year":"2022","unstructured":"Steele CD, et al. Signatures of copy number alterations in human cancer. Nature. 2022;606:984\u201391.","journal-title":"Nature"},{"key":"886_CR12","doi-asserted-by":"publisher","first-page":"11479","DOI":"10.1038\/ncomms11479","volume":"7","author":"B Pereira","year":"2016","unstructured":"Pereira B, et al. The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nat Commun. 2016;7:11479.","journal-title":"Nat Commun"},{"key":"886_CR13","doi-asserted-by":"publisher","first-page":"101430","DOI":"10.1016\/j.gendis.2024.101430","volume":"12","author":"Y Wang","year":"2025","unstructured":"Wang Y, Rozen V, Zhao Y, Wang Z. Oncogenic activation of PIK3CA in cancers: emerging targeted therapies in precision oncology. Genes Dis. 2025;12:101430.","journal-title":"Genes Dis"},{"key":"886_CR14","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ccell.2018.03.007","volume":"33","author":"AM Taylor","year":"2018","unstructured":"Taylor AM, et al. Genomic and functional approaches to Understanding cancer aneuploidy. Cancer Cell. 2018;33:676\u2013e6893.","journal-title":"Cancer Cell"},{"key":"886_CR15","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.omto.2020.05.010","volume":"17","author":"F Kou","year":"2020","unstructured":"Kou F, Wu L, Ren X, Yang L. Chromosome abnormalities: new insights into their clinical significance in cancer. Mol Ther Oncolytics. 2020;17:562\u201370.","journal-title":"Mol Ther Oncolytics"},{"key":"886_CR16","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.neo.2021.06.003","volume":"23","author":"B Gao","year":"2021","unstructured":"Gao B, et al. Genomic landscape and evolution of arm aneuploidy in lung adenocarcinoma. Neoplasia N Y N. 2021;23:870\u20138.","journal-title":"Neoplasia N Y N"},{"key":"886_CR17","doi-asserted-by":"crossref","unstructured":"Hieronymus H et al. Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death. eLife 7, e37294.","DOI":"10.7554\/eLife.37294"},{"key":"886_CR18","doi-asserted-by":"publisher","first-page":"e000374","DOI":"10.1136\/jitc-2019-000374","volume":"8","author":"Z Lu","year":"2020","unstructured":"Lu Z, et al. Tumor copy-number alterations predict response to immune-checkpoint-blockade in Gastrointestinal cancer. J Immunother Cancer. 2020;8:e000374.","journal-title":"J Immunother Cancer"},{"key":"886_CR19","doi-asserted-by":"crossref","unstructured":"Replogle JM et al. Aneuploidy increases resistance to chemotherapeutics by antagonizing cell division. Proc Natl Acad Sci USA. 2020;117:30566\u201330576.","DOI":"10.1073\/pnas.2009506117"},{"key":"886_CR20","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41586-018-0321-x","volume":"559","author":"P-R Loh","year":"2018","unstructured":"Loh P-R, et al. Insights into clonal haematopoiesis from 8,342 mosaic chromosomal alterations. Nature. 2018;559:350\u20135.","journal-title":"Nature"},{"key":"886_CR21","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41586-020-2430-6","volume":"584","author":"P-R Loh","year":"2020","unstructured":"Loh P-R, Genovese G, McCarroll SA. Monogenic and polygenic inheritance become instruments for clonal selection. Nature. 2020;584:136\u201341.","journal-title":"Nature"},{"key":"886_CR22","doi-asserted-by":"publisher","first-page":"7009","DOI":"10.1038\/s41467-023-42908-w","volume":"14","author":"AK Ressler","year":"2023","unstructured":"Ressler AK, et al. Single-nucleus DNA sequencing reveals hidden somatic loss-of-heterozygosity in cerebral cavernous malformations. Nat Commun. 2023;14:7009.","journal-title":"Nat Commun"},{"key":"886_CR23","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1016\/j.ajhg.2024.08.020","volume":"111","author":"E DeBose-Scarlett","year":"2024","unstructured":"DeBose-Scarlett E, et al. Somatic mutations in arteriovenous malformations in hereditary hemorrhagic telangiectasia support a bi-allelic two-hit mutation mechanism of pathogenesis. Am J Hum Genet. 2024;111:2283\u201398.","journal-title":"Am J Hum Genet"},{"key":"886_CR24","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s41586-023-06266-3","volume":"619","author":"J Shih","year":"2023","unstructured":"Shih J, et al. Cancer aneuploidies are shaped primarily by effects on tumor fitness. Nature. 2023;619:793\u2013800.","journal-title":"Nature"},{"key":"886_CR25","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.ajhg.2012.09.004","volume":"91","author":"G Jun","year":"2012","unstructured":"Jun G, et al. Detecting and estimating contamination of human DNA samples in sequencing and Array-Based genotype data. Am J Hum Genet. 2012;91:839\u201348.","journal-title":"Am J Hum Genet"},{"key":"886_CR26","doi-asserted-by":"publisher","first-page":"5436","DOI":"10.1038\/s41467-019-13225-y","volume":"10","author":"O Delaneau","year":"2019","unstructured":"Delaneau O, Zagury J-F, Robinson MR, Marchini JL, Dermitzakis ET. Accurate, scalable and integrative haplotype Estimation. Nat Commun. 2019;10:5436.","journal-title":"Nat Commun"},{"key":"886_CR27","doi-asserted-by":"publisher","unstructured":"Justin Zook. Genome In A Bottle - v3.0 Genome Stratifications. 110 files, 2.29 GB National Institute of Standards and Technology https:\/\/doi.org\/10.18434\/MDS2-2499 (2021).","DOI":"10.18434\/MDS2-2499"},{"key":"886_CR28","doi-asserted-by":"publisher","first-page":"100356","DOI":"10.1016\/j.xgen.2023.100356","volume":"3","author":"EA Maury","year":"2023","unstructured":"Maury EA, et al. Schizophrenia-associated somatic copy-number variants from 12,834 cases reveal recurrent NRXN1 and ABCB11 disruptions. Cell Genomics. 2023;3:100356.","journal-title":"Cell Genomics"},{"key":"886_CR29","doi-asserted-by":"publisher","unstructured":"Anderson MJ. Permutational multivariate analysis of variance (PERMANOVA). In: Wiley StatsRef: Statistics Reference Online 1\u201315 (John Wiley & Sons, Ltd, 2017). https:\/\/doi.org\/10.1002\/9781118445112.stat07841","DOI":"10.1002\/9781118445112.stat07841"},{"key":"886_CR30","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1038\/s41467-017-01329-2","volume":"8","author":"M M\u00e9ndez-Pertuz","year":"2017","unstructured":"M\u00e9ndez-Pertuz M, et al. Modulation of telomere protection by the PI3K\/AKT pathway. Nat Commun. 2017;8:1278.","journal-title":"Nat Commun"},{"key":"886_CR31","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1136\/jmg-2024-110569","volume":"62","author":"E DeBose-Scarlett","year":"2025","unstructured":"DeBose-Scarlett E, et al. Arteriovenous malformation from a JP-HHT patient harbors two second hit somatic DNA alterations in SMAD4. J Med Genet. 2025;62:281\u20138.","journal-title":"J Med Genet"},{"key":"886_CR32","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3389\/fneur.2018.00383","volume":"9","author":"C Thomas","year":"2018","unstructured":"Thomas C, et al. A novel PKD1 mutation associated with autosomal dominant kidney disease and cerebral cavernous malformation. Front Neurol. 2018;9:383.","journal-title":"Front Neurol"},{"key":"886_CR33","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1002\/ajmg.a.36041","volume":"161","author":"A Ishikawa","year":"2013","unstructured":"Ishikawa A, et al. Pure duplication of 19p13.3. Am J Med Genet A. 2013;161:2300\u20134.","journal-title":"Am J Med Genet A"},{"key":"886_CR34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12964-023-01301-2","volume":"22","author":"Y Li","year":"2024","unstructured":"Li Y, et al. Transcriptomic signatures of individual cell types in cerebral cavernous malformation. Cell Commun Signal CCS. 2024;22:23.","journal-title":"Cell Commun Signal CCS"},{"key":"886_CR35","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.3390\/cells10113129","volume":"10","author":"E Pons-Tostivint","year":"2021","unstructured":"Pons-Tostivint E, Lugat A, Fontenau J-F, Denis MG, Bennouna J. STK11\/LKB1 modulation of the immune response in lung cancer: from biology to therapeutic impact. Cells. 2021;10:3129.","journal-title":"Cells"},{"key":"886_CR36","doi-asserted-by":"publisher","first-page":"e9611","DOI":"10.1002\/ccr3.9611","volume":"12","author":"H Zheng","year":"2024","unstructured":"Zheng H, et al. Genetic analysis of 17q terminal partial trisomy. Clin Case Rep. 2024;12:e9611.","journal-title":"Clin Case Rep"},{"key":"886_CR37","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.tjog.2014.05.008","volume":"54","author":"R Bruno","year":"2015","unstructured":"Bruno R, et al. A 17q duplication prenatally detected. Taiwan J Obstet Gynecol. 2015;54:326\u20139.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"886_CR38","first-page":"1627","volume":"33","author":"M Lastowska","year":"1997","unstructured":"Lastowska M, et al. Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients. U.K. Children\u2019s cancer study group and the U.K. cancer cytogenetics group. Eur J Cancer Oxf Engl 1990. 1997;33:1627\u201333.","journal-title":"Eur J Cancer Oxf Engl 1990"},{"key":"886_CR39","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3390\/cancers16020338","volume":"16","author":"V Mlakar","year":"2024","unstructured":"Mlakar V, et al. 17q gain in neuroblastoma: a review of clinical and biological implications. Cancers. 2024;16:338.","journal-title":"Cancers"},{"key":"886_CR40","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1684\/epd.2015.0746","volume":"17","author":"A Okumura","year":"2015","unstructured":"Okumura A, et al. Phenotypes of children with 20q13.3 microdeletion affecting KCNQ2 and CHRNA4. Epileptic Disord Int Epilepsy J Videotape. 2015;17:165\u201371.","journal-title":"Epileptic Disord Int Epilepsy J Videotape"},{"key":"886_CR41","doi-asserted-by":"crossref","unstructured":"Hasstedt SJ et al. A Copy Number Variant on Chromosome 20q13.3 Implicated in Thinness and Severe Obesity. J Obes. 2015;2015:623431.","DOI":"10.1155\/2015\/623431"},{"key":"886_CR42","doi-asserted-by":"publisher","first-page":"19351","DOI":"10.1038\/s41598-021-98647-9","volume":"11","author":"H Eren Gozel","year":"2021","unstructured":"Eren Gozel H, K\u00f6k K, Ozlen F, Isler C, Pence S. A novel insight into differential expression profiles of sporadic cerebral cavernous malformation patients with different symptoms. Sci Rep. 2021;11:19351.","journal-title":"Sci Rep"},{"key":"886_CR43","doi-asserted-by":"publisher","first-page":"e179782","DOI":"10.1172\/JCI179782","volume":"135","author":"A Holm","year":"2025","unstructured":"Holm A, et al. An endothelial SOX18-mevalonate pathway axis enables repurposing of Statins for infantile hemangioma. J Clin Invest. 2025;135:e179782.","journal-title":"J Clin Invest"},{"key":"886_CR44","doi-asserted-by":"publisher","first-page":"e43026","DOI":"10.7554\/eLife.43026","volume":"8","author":"J Overman","year":"2019","unstructured":"Overman J, et al. R-propranolol is a small molecule inhibitor of the SOX18 transcription factor in a rare vascular syndrome and hemangioma. eLife. 2019;8:e43026.","journal-title":"eLife"},{"key":"886_CR45","doi-asserted-by":"crossref","unstructured":"Zhao L, Vogt PK. Helical domain and kinase domain mutations in p110\u03b1 of phosphatidylinositol 3-kinase induce gain of function by different mechanisms. Proc Natl Acad Sci USA. 2008;105:2652\u20132657.","DOI":"10.1073\/pnas.0712169105"},{"key":"886_CR46","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41467-023-35789-6","volume":"14","author":"ML Jenkins","year":"2023","unstructured":"Jenkins ML, et al. Oncogenic mutations of PIK3CA lead to increased membrane recruitment driven by reorientation of the ABD, p85 and C-terminus. Nat Commun. 2023;14:181.","journal-title":"Nat Commun"},{"key":"886_CR47","doi-asserted-by":"publisher","first-page":"bbad053","DOI":"10.1093\/bib\/bbad053","volume":"24","author":"Z Tao","year":"2023","unstructured":"Tao Z, et al. The repertoire of copy number alteration signatures in human cancer. Brief Bioinform. 2023;24:bbad053.","journal-title":"Brief Bioinform"},{"key":"886_CR48","doi-asserted-by":"publisher","first-page":"100815","DOI":"10.1016\/j.gimo.2023.100815","volume":"1","author":"BA Mojarad","year":"2023","unstructured":"Mojarad BA, et al. Profiling PIK3CA variants in disorders of somatic mosaicism. Genet Med Open. 2023;1:100815.","journal-title":"Genet Med Open"},{"key":"886_CR49","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/onc.2015.196","volume":"35","author":"E Marques","year":"2016","unstructured":"Marques E, et al. Par6G suppresses cell proliferation and is targeted by loss-of-function mutations in multiple cancers. Oncogene. 2016;35:1386\u201398.","journal-title":"Oncogene"},{"key":"886_CR50","doi-asserted-by":"publisher","first-page":"48","DOI":"10.20517\/2574-1209.2021.64","volume":"5","author":"J Zhang","year":"2021","unstructured":"Zhang J, Abou-Fadel JS. Calm the raging hormone - a new therapeutic strategy involving progesterone-signaling for hemorrhagic CCMs. Vessel Plus. 2021;5:48.","journal-title":"Vessel Plus"},{"key":"886_CR51","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12964-022-00926-z","volume":"20","author":"J Abou-Fadel","year":"2022","unstructured":"Abou-Fadel J, et al. CCM signaling complex (CSC) couples both classic and non-classic progesterone receptor signaling. Cell Commun Signal. 2022;20:120.","journal-title":"Cell Commun Signal"},{"key":"886_CR52","doi-asserted-by":"publisher","unstructured":"Kraft M, et al. Angiopoietin\u2013TIE2 feedforward circuit promotes PIK3CA-driven venous malformations. Nat Cardiovasc Res. 2025;1\u201320. https:\/\/doi.org\/10.1038\/s44161-025-00655-9.","DOI":"10.1038\/s44161-025-00655-9"},{"key":"886_CR53","doi-asserted-by":"publisher","first-page":"894","DOI":"10.18632\/oncoscience.255","volume":"2","author":"E Marques","year":"2015","unstructured":"Marques E, Klefstr\u00f6m J. Par6 family proteins in cancer. Oncoscience. 2015;2:894\u20135.","journal-title":"Oncoscience"},{"key":"886_CR54","first-page":"860","volume":"126","author":"V Dormoy","year":"2013","unstructured":"Dormoy V, Tormanen K, S\u00fctterlin C. Par6\u03b3 is at the mother centriole and controls centrosomal protein composition through a Par6\u03b1-dependent pathway. J Cell Sci. 2013;126:860\u201370.","journal-title":"J Cell Sci"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-025-00886-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-025-00886-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-025-00886-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T03:02:10Z","timestamp":1768359730000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40246-025-00886-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["886"],"URL":"https:\/\/doi.org\/10.1186\/s40246-025-00886-8","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"I.A. is a consultant for Neurelis, Inc. The remaining authors have declared no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}